Subscribe to The Australian | Newspaper home delivery, website, iPad, iPhone & Android apps
Vesna Poljak Business Editor Vesna Poljak has over two decades of experience in Australian business journalism, specializing in…
Gene therapy access is limited by cost and geography : NPR
Dustin Vidrine stands outside his house in Lafayette, La. Annie Flanagan for NPR hide caption toggle caption Annie…
Subscribe to The Australian | Newspaper home delivery, website, iPad, iPhone & Android apps
Vesna Poljak Business Editor Vesna Poljak has over two decades of experience in Australian business journalism, specializing in…
Novartis to build new radioligand therapy site in Denton, Texas, delivering more next‑generation treatments to patients
Facility expected to be operational in 2028 in Dallas-Fort Worth area, expanding largest RLT manufacturing network in USSite…
Temporary reprieve for Gaza healthcare system as Israel’s attempt to block Doctors Without Borders and other aid groups is stopped
From his tent perched on top of the rubble of a former building in southern Gaza, Jibril Najjar…
GEMMABio Announces First Patient Dosed in CHARISMA Trial of GB221, Investigational Next‑Generation Gene Therapy for Spinal Muscular Atrophy Type 1 (SMA1)
-U.S. FDA grants GB221 rare pediatric disease designation PHILADELPHIA, Feb. 26, 2026 /PRNewswire/ — Gemma Biotherapeutics (“GEMMABio”), a…
American heart health worsening — Harvard Gazette
Treatments for cardiovascular conditions have never been better. Knowledge about how to improve heart health has steadily improved.…
Tech sector under pressure: Energy and healthcare offer a safe haven
Sector Overview The stock market today showcases a complex tapestry of trends and fluctuations. The technology sector is…
2 Top Healthcare Stocks to Buy in February
Will the healthcare sector finally rebound in 2026, after underperforming broader equities in recent years? It’s hard to…
China’s healthcare system races to catch up with rapid ageing
TOP POLICY PRIORITY As demographic pressures mount, China is increasingly looking outward for expertise and investment to upgrade…
Science of sex and gender being misrepresented by Trump officials, experts warn | US healthcare
As more health systems end gender-affirming care for patients amid a crackdown from the Trump administration, scientists and…
Is this ASX healthcare stock a buy, hold or sell after jumping 10% on earnings results?
ASX healthcare stock Saluda Medical Inc (ASX: SLD) has endured a rough 12 months. So far in 2026,…